YCYang Chen

Yang Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yang Chen has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Shining Cai

    Department of Pharmaceutical Sciences, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong 519041, P.R. China

    5 shared publications
  • Kamran Habib

    State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guizhou, China

    4 shared publications
  • Li-Li Liu

    Department of Entomology and Plant Pathology; Faculty of Agriculture; Chiang Mai University; Chiang Mai 50200; Thailand

    4 shared publications
  • Qirui Li

    State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guizhou, China

    4 shared publications
  • Xing-Yu Luo

    State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences Guizhou Medical University Gui’an New District P. R. China

    4 shared publications
  • Yarong Wang

    Department of Pharmaceutical Sciences, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong 519041, P.R. China

    4 shared publications

Latest Publications

  • A New Species of Diaporthe Section Betulicola (Diaporthomycetidae, Diaporthales) From China

    by Yi Lan Jin, Xing Yu Luo, Kamran Habib, Yu Lin Ren, Qing Yang, Li Li Liu, Chanhom Loinheuang, Yang Chen, Qi Rui Li

    A new species in Diaporthaceae, Diaporthe fengtaiensis sp. nov., is described and illustrated from Southwestern China. A comparative morpho‐anatomical study and multilocus phylogenetic analysis (ITS, CAL , HIS , TEF1‐α , TUB2 ) confirmed its position within the section Betulicola of the genus Diaporthe . The taxon is characterized by immersed ascomata (270–420 × 290–410 µm), relatively large asci (70–115 × 9.5–13.5 µm), and 1‐septate, fusiform ascospores (18.5–25.6 × 4.5–6.5 µm). Its positioning in a separate branch in the phylogenetic tree makes it distinct from the other known species of the section. A complete taxonomic treatment, based on two collected specimens, is provided along with molecular phylogenetic analyses.

  • Acrogenospora tongrenensis sp. nov. (Minutisphaerales, Dothideomycetes), a freshwater hyphomycete from Guizhou, China

    by Wen-Mei Li, Qin-Fang Zhang, Li-Li Liu, Xing-Yu Luo, Kamran Habib, Xiang-Chun Shen, Yang Chen, Qi-Rui Li

    During a study on the diversity and taxonomy of hyphomycetous freshwater fungi in Guizhou, China, two strains of Acrogenospora were isolated from decaying wood. Morphological and multilocus phylogenetic analyses of ITS, LSU, SSU, rpb2 and tef1-α sequence data revealed that the two strains represent an undescribed taxon, which we here described and illustrated under the name Acrogenospora tongrenensis sp. nov. According to the phylogenetic analysis the new species is closely related to A. stellata, but can be distinguished by its longer conidiophores (300–700 × 5–8 µm vs. 200–570 × 6–10 µm) and larger, acropleurogenous conidia (34–44 × 25–37 µm vs. acrogenous 25–30 × 15–20 µm). A detailed description, illustrations, and a phylogenetic tree are provided to support the recognition and accurate identification of this new species.

  • Thysanorea tongrensis sp. nov. (Herpotrichiellaceae, Chaetothyriales), a novel species isolated from decaying wood in Guizhou, China

    by Wenmei Li, Lili Liu, Qinfang Zhang, Kamran Habib, Xingyu Luo, Yulin Ren, Pingzhu Lu, Yilan Jin, Chuangen Lin, Yang Chen, et al.

    Thysanorea tongrensis sp. nov., a novel saprobic fungus colonizing decaying wood, is described and illustrated based on specimens collected in the Fodingshan National Nature Reserve, Guizhou Province, China. Phylogenetic analyses based on a combined dataset of ITS, LSU, and SSU sequences, along with detailed morphological comparisons, indicate that the new species is closely related to Thysanorea curvata. However, T. tongrensis is distinguished by its longer conidiophores (180–415 µm vs. 150–230 µm) and larger hyaline conidia (24–38 × 5–8 µm), in contrast to the smaller, pale brown conidia (16–18 × 6.5–7.5 µm) of T. curvata. Detailed morphological descriptions, illustrations, and phylogenetic analyses of the new species are presented.

  • A New Bambusicolous Species of Spirodecospora (Spirodecosporaceae) from Yunnan, China, with a Key to Known Species

    by Xingyu Luo, Kamran Habib, Yulin Ren, Changtao Lu, Qinfang Zhang, Lili Liu, Jichuan Kang, Yang Chen, Qirui Li

    A new species of the genus Spirodecospora (Spirodecosporaceae, Xylariales) from Yunnan, China, is described and illustrated here under the name of Spirodecospora brevifissurata. It is characterized by deeply immersed, large ascomata, a square-shaped ascal apical apparatus, and relatively large ascospores with a single median linear striation, half the length of the ascospore, surrounded by a mucilaginous sheath. Phylogenetic analysis based on combined ITS, LSU and rpb2 sequences places the new taxon relative to S. jichuanenii, from which it differs in having larger ascomata and larger ascospores. Descriptions and illustrations of the new species are provided, as well as a key to the species of Spirodecospora known to the world.

  • Open Access

    Inflammation-oriented montmorillonite adjuvant enhanced oral delivery of anti-TNF-α nanobody against inflammatory bowel disease

    by Baolian Huang, Te Yin, Shuilian Fu, Lina Liu, Chen Yang, Lulu Zhou, Xing Liu, Hongqin Zhuang, Zhiting Cao, Zichun Hua

    Oral delivery of proteins faces challenges due to the harsh conditions of the gastrointestinal (GI) tract, including gastric acid and intestinal enzyme degradation. Permeation enhancers are limited in their ability to deliver proteins with high molecular weight and can potentially cause toxicity by opening tight junctions. To overcome these challenges, we propose the use of montmorillonite (MMT) as an adjuvant that possesses both inflammation-oriented abilities and the ability to regulate gut microbiota. This adjuvant can be used as a universal protein oral delivery technology by fusing with advantageous binding amino acid sequences. We demonstrated that anti-TNF-α nanobody (V II ) can be intercalated into the MMT interlayer space. The carboxylate groups (–COOH) of aspartic acid (D) and glutamic acid (E) interact with the MMT surface through electrostatic interactions with sodium ions (Na + ). The amino groups (NH 2 ) of asparagine (N) and glutamine (Q) are primarily attracted to the MMT layers through hydrogen bonding with oxygen atoms on the surface. This binding mechanism protects V II from degradation and ensures its release in the intestinal tract, as well as retaining biological activity, leading to significantly enhanced therapeutic effects on colitis. Furthermore, V II @MMT increases the abundance of short-chain fatty acids (SCFAs)-producing strains, including Clostridia, Prevotellaceae, Alloprevotella, Oscillospiraceae, Clostridia_vadinBB60_group, and Ruminococcaceae, therefore enhance the production of SCFAs and butyrate, inducing regulatory T cells (Tregs) production to modulate local and systemic immune homeostasis. Overall, the MMT adjuvant provides a promising universal strategy for protein oral delivery by rational designed protein.


  • Characterization of Crocetin‐Monoglucuronide as a Neuron‐Protective Metabolite of Crocin‐1

    by Anyun Zhu, Chuyu Lao, Ze Wang, Yang Chen, Chuan Bai

    Scope: Crocins are important apocarotenoids in the extract of saffron (Crocus sativus L.) and fruits of gardenia (Gardenia jasminoides E.). Crocins have shown versatile biological activities and thus they have been considered to be promising therapeutics for neurodegenerative and heart diseases. Metabolism studies report that crocetin‐monoglucuronide (CM) is produced and detected in rat blood plasma after oral administration of crocins. However, due to the lack of standard compound of CM, its unambiguous identification, quantification, and bioactivity studies have been hindered.Methods and results: CM is synthetized and its existence in blood plasma in Sprague–Dawley (SD) rats is quantified. The pharmacokinetic studies show that CM is produced in blood and brain after oral administration of crocin‐1. It is then discovered that CM possesses neuroprotective activity against beta‐amyloid (Aβ) toxicity in PC‐12 cells and drosophila models. The enzymatic assay shows that CM can effectively inhibit AChE and docking studies indicate that CM may bind in the gorge channel of AChE.Conclusion: The work discovered that CM is a neuron‐protective metabolite of the orally administrated crocin‐1. It is demonstrated that AChE can be one of the targets of CM in its neuron‐protective activity.


  • Comparative anti-arthritic investigation of iridoid glycosides and crocetin derivatives from Gardenia jasminoides Ellis in Freund's complete adjuvant-induced arthritis in rats

    by Yaya Hu, Xin Liu, Qiang Xia, Tianpeng Yin, Chuan Bai, Ze Wang, Lianfeng Du, Xiaobo Li, Wenjun Wang, Lin Sun, et al.


  • Open Access

    Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen (Salvia miltiorrhiza)

    by Jia Zou, Yang Chen, Maggie Pui Man Hoi, Jun Li, Tao Wang, Ying Zhang, Yu Feng, Jianli Gao, Simon Ming Yuen Lee, Guozhen Cui

    Danshen (Salvia miltiorrhiza) is a well‐known herb in Traditional Chinese Medicine (TCM) for treating cardiovascular diseases, but the underlying mechanism remains to be fully elucidated. Here, we showed that Danshen and its active ingredient rosmarinic acid exhibited antiplatelet effects through the inhibition of ERp57, a member of protein disulfide isomerase (PDI) with potential roles in platelet aggregation. Danshen extract (DSE) exhibited potent inhibitory effects on the platelet aggregation induced by arachidonic acid‐ (AA‐) induced platelet aggregation and the enzymatic activity of ERp57. Rosmarinic acid was identified by virtual screening and molecular docking as one of the hit compounds for ERp57. In line with this, rosmarinic acid displayed significant inhibitory effect on ERp57 activity and inhibited AA‐induced platelet aggregation. Taken together, we demonstrated for the first time that DSE and rosmarinic acid displayed inhibitory effects on the catalytic activity of ERp57, providing evidence of the regulatory role of ERp57 underlying the antiplatelet effects of Danshen.


  • Open Access

    Ethanol extract of gardenia fruit alleviates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats

    by Xiaobo Li, Min Ma, Xianggui Zhang, Liang Deng, Yarong Wang, Zhuang Bian, Shining Cai, Bangya Peng, Jiangquan Yang, Yang Chen

    Gardenia fruit has been used in traditional Chinese medicine for thousands of years. A previous study by the present authors indicated that the ethanol extract of gardenia fruits (EEG) primarily contains eight constituents. In the present study, the potential effects of EEG on unilateral ureteral obstruction (UUO)-induced renal interstitial fibrosis were observed in rats. A total of 30 rats were randomly divided into three groups (n=10 each): Sham group, UUO group, and EEG group, which were administered with EEG (200 mg/kg/day) or the same volume of distilled water as a vehicle. UUO were established by ligating left ureter at two points and cut between the ligatures. All rats were sacrificed at 14 days after UUO operation. the present results demonstrated that EEG significantly elevated the expressions of vascular endothelial growth factor and E-cadherin induced by UUO (both P<0.05), and reduced levels of hypoxia-inducible factor-1α, transforming growth factor-β1, connective tissue growth factor and α-smooth muscle actin (all P<0.05). The present findings suggest that EEG is a potential novel renoprotective compound for renal fibrosis through inhibiting epithelial-to-mesenchymal transition.